# Advanced Breast Cancer Therapies

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/advanced-breast-cancer-therapies-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 247,419 |
| Description | This cluster of papers focuses on the use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, such as palbociclib, letrozole, ribociclib, and abemaciclib, in the treatment of hormone receptor-positive metastatic breast cancer. The papers cover various aspects including clinical trials, mechanisms of action, therapeutic resistance, combination strategies, and potential biomarkers. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | https://openalex.org/T12829 |
| Works | 36,060 |

## Topic researchers

Showing 12 of 20.

- [John P. A. Ioannidis](https://scholariq.org/researchers/john-p-a-ioannidis/)
- [Hagop M. Kantarjian](https://scholariq.org/researchers/hagop-m-kantarjian/)
- [Gordon B. Mills](https://scholariq.org/researchers/gordon-b-mills/)
- [Charles M. Perou](https://scholariq.org/researchers/charles-m-perou/)
- [Gordon K. Smyth](https://scholariq.org/researchers/gordon-k-smyth/)
- [Aviv Regev](https://scholariq.org/researchers/aviv-regev/)
- [Marc Ladanyi](https://scholariq.org/researchers/marc-ladanyi/)
- [Patrizio Lancellotti](https://scholariq.org/researchers/patrizio-lancellotti/)
- [Lewis C. Cantley](https://scholariq.org/researchers/lewis-c-cantley/)
- [Nikolaus Schultz](https://scholariq.org/researchers/nikolaus-schultz/)
- [Solomon H. Snyder](https://scholariq.org/researchers/solomon-h-snyder/)
- [Eric Van Cutsem](https://scholariq.org/researchers/eric-van-cutsem/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.